Bajaj Healthcare (BAJAJHCARE) | Stock Overview & Key Data
Bajaj Healthcare Performance Comparison
Stock Range
Today's Range
Low: ₹446.00
High: ₹454.00
on August 20, 2025
52 Week Range
Low: ₹333.80
High: ₹745.00
on October 25, 2024
on March 19, 2025
All-Time High: ₹745.00 on March 17, 2025
Explore how other Indian stocks compare to their 52-week ranges: View IN Market 52-Week Insights
Key Statistics
Market Cap
INR14.2B
EPS
15.10
P/E Ratio (TTM)
29.44
Forward P/E
N/A
P/B Ratio
3.01
PEG Ratio
0.66
Div. Yield
0.19%
ROE
8.47%
Beta
0.073
Debt to Equity
47.89
Financial Highlights
Profitability
Gross Margin
45.85%
Operating Margin
12.68%
Profit Margin
7.90%
Returns and Earnings
Return on Assets (TTM)
4.74%
Return on Equity (TTM)
8.47%
EBITDA
INR1.0B
Net Income (TTM)
INR470.8M
Growth
Revenue (TTM)
Revenue Per Share (TTM)
INR177.05
Quarterly Revenue Growth (YoY)
12.50%
Quarterly Earnings Growth (YoY)
65.90%
Dividend Information
Last 12-Month Dividend
₹1.00
Current Dividend Yield
0.19%
3-Year Average Dividend Yield
0.29%
3-Year Average Annual Dividend
₹1.17
3-Year Total Dividends
₹3.50
Ex-Dividend Date
September 23, 2024
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|---|---|---|
| Bajaj Healthcare BAJAJHCARE | 14.16B Small-cap | -2.96% | -13.50% | -21.01% | -34.80% | -28.93% | 9.57% | 22.74% | 23.58% |
| Sun Pharmaceutical SUNPHARMA | 3.94T Large-cap | 0.27% | -3.88% | -5.99% | -2.98% | -13.93% | -8.40% | 84.81% | 192.69% |
| Divi's Laboratories DIVISLAB | 1.64T Large-cap | 1.99% | -9.10% | -7.61% | 2.44% | 0.11% | 25.20% | 69.46% | 85.76% |
| Sun Pharma Advanced SPARC | 45.51B Small-cap | 4.19% | -8.09% | -11.48% | 12.35% | -26.33% | -34.00% | -36.71% | -22.67% |
| Aarti Drugs AARTIDRUGS | 44.80B Small-cap | 0.27% | -9.96% | 2.11% | 28.03% | 7.74% | -12.97% | 12.03% | -33.03% |
| Sequent Scientific SEQUENT | 43.92B Small-cap | 1.51% | -5.78% | -0.25% | 17.84% | -4.22% | 5.62% | 52.82% | 30.86% |
Ownership & Short Interest
Insider Ownership
64.20%
Institutional Ownership
1.88%
Shares Short
N/A
Short Ratio
N/A
Short % of Shares Outstanding
N/A
Average 10-Day Volume
89K
Average 90-Day Volume
206K
Bajaj Healthcare Recurring Investment / Dollar-Cost Averaging Calculator
Calculate how a regular investment in Bajaj Healthcare would have performed over time.
Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.
Frequently Asked Questions
- What is BAJAJHCARE's 52-week high and low?
- In the last 52 weeks, Bajaj Healthcare reached a high of ₹745.00 (on March 19, 2025) and a low of ₹333.80 (on October 25, 2024).
- What is the market cap and P/E ratio for BAJAJHCARE?
- Curious about Bajaj Healthcare's size and valuation? Its market capitalization stands at 14.16B. When it comes to valuation, the P/E ratio (trailing twelve months) is 29.44, and the forward P/E (looking ahead) is N/A.
- Does BAJAJHCARE pay dividends? If so, what's the yield?
- Yes, Bajaj Healthcare is a dividend-paying stock. Investors have recently enjoyed a trailing annual dividend yield of 0.19%, and the company has paid an average of ₹1.17 per share annually over the past 3 years.
- Who are Bajaj Healthcare's main competitors or similar companies to consider before investing?
When looking at Bajaj Healthcare, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return Sun Pharmaceutical
SUNPHARMA3.94T Healthcare Drug Manufacturers - Specialty & Generic -8.40% 84.81% Divi's Laboratories
DIVISLAB1.64T Healthcare Drug Manufacturers - Specialty & Generic 25.20% 69.46% Sun Pharma Advanced
SPARC45.51B Healthcare Drug Manufacturers - Specialty & Generic -34.00% -36.71% Aarti Drugs
AARTIDRUGS44.80B Healthcare Drug Manufacturers - Specialty & Generic -12.97% 12.03% Sequent Scientific
SEQUENT43.92B Healthcare Drug Manufacturers - Specialty & Generic 5.62% 52.82% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for Bajaj Healthcare Ltd.? (e.g., ROE, Debt/Equity)
- To get a sense of Bajaj Healthcare's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is 8.47%, the Debt to Equity ratio from the most recent quarter is 47.89, and its Gross Profit Margin stands at 45.85%.
- What is the recent revenue and earnings growth for BAJAJHCARE?
- Looking at Bajaj Healthcare's growth, its revenue over the trailing twelve months (TTM) was INR6B. Compared to the same quarter last year (YoY), quarterly revenue grew by 12.50%, and quarterly earnings saw a YoY growth of 65.90%.
- How much of BAJAJHCARE stock is held by insiders and institutions?
- Wondering who owns Bajaj Healthcare stock? Company insiders (like executives and directors) hold about 64.20% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 1.88%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.